跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-TADALAFIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-TADALAFIL
Authorized
STANDARD
MAR-TADALAFIL
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fccc19ef12f3cfa2
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
fccc19ef12f3cfa2
Drug Approval Canada Name
MAR-TADALAFIL
Product Name
MAR-TADALAFIL
Status
Dormant
Status Date
2018-08-01
Original Market Date
2016-07-13
Din
02452286
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:12.12
Atc Original
G04BE08 TADALAFIL
Atc Name
g 04 be 08
Aig Number
0149485003
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
TADALAFIL
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fccc19ef12f3cfa2
Type
Standard
Back to Health Canada Approvals